Development of a fingerprinting panel using medically relevant polymorphisms
<p>Abstract</p> <p>Background</p> <p>For population based biorepositories to be of use, rigorous quality control and assurance must be maintained. We have designed and validated a panel of polymorphisms for individual sample identification consisting of 36 common polymo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-04-01
|
| Series: | BMC Medical Genomics |
| Online Access: | http://www.biomedcentral.com/1755-8794/2/17 |
| _version_ | 1818560907003822080 |
|---|---|
| author | McCarty Catherine A Ivacic Lynn C Cross Deanna S |
| author_facet | McCarty Catherine A Ivacic Lynn C Cross Deanna S |
| author_sort | McCarty Catherine A |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>For population based biorepositories to be of use, rigorous quality control and assurance must be maintained. We have designed and validated a panel of polymorphisms for individual sample identification consisting of 36 common polymorphisms that have been implicated in a wide range of diseases and an additional sex marker. This panel uniquely identifies our biorepository of approximately 20,000 samples and would continue to uniquely identify samples in biorepositories of over 100 million samples.</p> <p>Methods</p> <p>A panel of polymorphisms associated with at least one disease state in multiple populations was constructed using a cut-off of 0.20 or greater confirmed minor allele frequency in a European Caucasian population. The fingerprinting assay was tested using the MALDI-TOF mass spectrometry method of allele determination on a Sequenom platform with a panel of 28 Caucasian HapMap samples; the results were compared with known genotypes to ensure accuracy. The frequencies of the alleles were compared to the expected frequencies from dbSNP and any genotype that did not achieve Hardy Weinberg equilibrium was excluded from the final assay.</p> <p>Results</p> <p>The final assay consisted of the AMG sex marker and 36 medically relevant polymorphisms with representation on each chromosome, encompassing polymorphisms on both the Illumina 550K bead array and the Affymetrix 6.0 chip (with over a million polymorphisms) platform. The validated assay has a P(ID) of 6.132 × 10<sup>-15 </sup>and a P<sub>sib</sub>(ID) of 3.077 × 10<sup>-8</sup>. This assay allows unique identification of our biorepository of 20,000 individuals as well and ensures that as we continue to recruit individuals they can be uniquely fingerprinted. In addition, diseases such as cancer, heart disease diabetes, obesity, and respiratory disease are well represented in the fingerprinting assay.</p> <p>Conclusion</p> <p>The polymorphisms in this panel are currently represented on a number of common genotyping platforms making QA/QC flexible enough to accommodate a large number of studies. In addition, this panel can serve as a resource for investigators who are interested in the effects of disease in a population, particularly for common diseases.</p> |
| first_indexed | 2024-12-14T00:44:16Z |
| format | Article |
| id | doaj.art-d72885c05130495daf6e86c037e3476d |
| institution | Directory Open Access Journal |
| issn | 1755-8794 |
| language | English |
| last_indexed | 2024-12-14T00:44:16Z |
| publishDate | 2009-04-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Medical Genomics |
| spelling | doaj.art-d72885c05130495daf6e86c037e3476d2022-12-21T23:24:12ZengBMCBMC Medical Genomics1755-87942009-04-01211710.1186/1755-8794-2-17Development of a fingerprinting panel using medically relevant polymorphismsMcCarty Catherine AIvacic Lynn CCross Deanna S<p>Abstract</p> <p>Background</p> <p>For population based biorepositories to be of use, rigorous quality control and assurance must be maintained. We have designed and validated a panel of polymorphisms for individual sample identification consisting of 36 common polymorphisms that have been implicated in a wide range of diseases and an additional sex marker. This panel uniquely identifies our biorepository of approximately 20,000 samples and would continue to uniquely identify samples in biorepositories of over 100 million samples.</p> <p>Methods</p> <p>A panel of polymorphisms associated with at least one disease state in multiple populations was constructed using a cut-off of 0.20 or greater confirmed minor allele frequency in a European Caucasian population. The fingerprinting assay was tested using the MALDI-TOF mass spectrometry method of allele determination on a Sequenom platform with a panel of 28 Caucasian HapMap samples; the results were compared with known genotypes to ensure accuracy. The frequencies of the alleles were compared to the expected frequencies from dbSNP and any genotype that did not achieve Hardy Weinberg equilibrium was excluded from the final assay.</p> <p>Results</p> <p>The final assay consisted of the AMG sex marker and 36 medically relevant polymorphisms with representation on each chromosome, encompassing polymorphisms on both the Illumina 550K bead array and the Affymetrix 6.0 chip (with over a million polymorphisms) platform. The validated assay has a P(ID) of 6.132 × 10<sup>-15 </sup>and a P<sub>sib</sub>(ID) of 3.077 × 10<sup>-8</sup>. This assay allows unique identification of our biorepository of 20,000 individuals as well and ensures that as we continue to recruit individuals they can be uniquely fingerprinted. In addition, diseases such as cancer, heart disease diabetes, obesity, and respiratory disease are well represented in the fingerprinting assay.</p> <p>Conclusion</p> <p>The polymorphisms in this panel are currently represented on a number of common genotyping platforms making QA/QC flexible enough to accommodate a large number of studies. In addition, this panel can serve as a resource for investigators who are interested in the effects of disease in a population, particularly for common diseases.</p>http://www.biomedcentral.com/1755-8794/2/17 |
| spellingShingle | McCarty Catherine A Ivacic Lynn C Cross Deanna S Development of a fingerprinting panel using medically relevant polymorphisms BMC Medical Genomics |
| title | Development of a fingerprinting panel using medically relevant polymorphisms |
| title_full | Development of a fingerprinting panel using medically relevant polymorphisms |
| title_fullStr | Development of a fingerprinting panel using medically relevant polymorphisms |
| title_full_unstemmed | Development of a fingerprinting panel using medically relevant polymorphisms |
| title_short | Development of a fingerprinting panel using medically relevant polymorphisms |
| title_sort | development of a fingerprinting panel using medically relevant polymorphisms |
| url | http://www.biomedcentral.com/1755-8794/2/17 |
| work_keys_str_mv | AT mccartycatherinea developmentofafingerprintingpanelusingmedicallyrelevantpolymorphisms AT ivaciclynnc developmentofafingerprintingpanelusingmedicallyrelevantpolymorphisms AT crossdeannas developmentofafingerprintingpanelusingmedicallyrelevantpolymorphisms |